RaabW.Psoriasis therapy with fumaric acid and fumaric acid esters. Z Hautkr1984; 59: 671–679.
2.
NieboerC., de HoopD., van LoenenA.C., LangendijkP.N., van DijkE.Systemic therapy with fumaric acid derivates: new possibilities in the treatment of psoriasis. J Am Acad Dermatol1989; 20: 601–608.
3.
HoefnagelJ.J., ThioH.B., WillemzeR., Bouwes BavinckJ.N.Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis. Br J Dermatol2003; 149: 363–369.
4.
OrmerodA.D., MrowietzU.Fumaric acid ester, their place in the treatment of psoriasis. Br J Dermatol2004; 150: 630–632.
5.
WalshN.Fumaric acid esters emerging as treatment for severe psoriasis. Skin & Allergy News2004; 35: 5.
6.
Ortiz-UrdaS., RappersbergerK.New immunosuppressive agents for treating psoriasis. Hautarzt2003; 54: 230–236.
7.
CarboniI., De FeliceC., De SimoniI., SodaR., ChimentiS.Fumaric acid esters in the treatment of psoriasis: an Italian experience. J Dermatolog Treat2004; 15: 23–26.
8.
MrowietzU., ChristophersE., AltmeyerP.Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study: German multicentre study. Br J Dermatol1998; 138: 456–460.
9.
HoxtermannS., NuchelC., AltmeyerP.Fumaric acid esters suppress peripheral CD4- and CD8-positive lymphocytes in psoriasis. Dermatolog1998; 196: 223–230.
10.
RaschkaC., KochH.J.Long-term treatment of psoriasis using fumaric acid preparations can be associated with severe proximal tubular damage. Hum Exp Toxicol1999; 18: 738–739.
